You are here

  • Home
  • Archive
  • Volume 14, Issue 4
  • Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial

Article metrics

Article menu
Intensive care
Protocol
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial

 

Online download statistics by month:

Online download statistics by month: April 2024 to June 2025

AbstractFullPdf
Apr 2024603619113
May 202441040886
Jun 202430530042
Jul 202431230835
Aug 202426926841
Sep 202430129826
Oct 2024757431
Nov 2024656425
Dec 2024524634
Jan 2025545330
Feb 2025989826
Mar 2025616042
Apr 2025464226
May 2025464528
Jun 202511107
Total27082693592